Platelet activating factor causes a rapid increase in activity of prior expressed tissue factor on monocyte surface membrane
スポンサーリンク
概要
著者
-
Kobayashi Tohru
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kinoshita T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kurokawa T
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Nishida Junji
Department Of Hematology Omiya Medical Center Jichi Medical School
-
Nishida Junji
Department Of Medicine Teikyo University School Of Medicine
-
OGUCHI Atsushi
Department of Medicine, Teikyo University School of Medicine
-
MORIOKA Machiko
Department of Medicine, Teikyo University School of Medicine
-
OBI Naomi
Department of Medicine, Teikyo University School of Medicine
-
KINOSHITA Tadatoshi
Department of Medicine, Teikyo University School of Medicine
-
Obi Naomi
Department Of Medicine Teikyo University School Of Medicine
-
Oguchi Atsushi
Department Of Medicine Teikyo University School Of Medicine
-
Morioka Machiko
Department Of Medicine Teikyo University School Of Medicine
-
KINOSHITA Tadatoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- PJ-102 Randomized Comparison of Aggressive Versus Less Aggressive Debulking with Directional Atherectomy before Stenting : A Serial 3-Dimentsional Intravascular Ultrasound Study(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 4 (IHD) : PJ
- PE-126 Six-Year Clinical Outcome of directional coronary atherectomy (DCA) in treating left main trunk (LMT) lesions(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 7 (IHD) : PE22)(Poster Session (English))
- PE-125 Efficacy of Continuous Hemodiafiltration during and after Percutanious Coronary Intervention in Patients with Mild Renal Dysfunction(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 7 (IHD) : PE22)(Poster Session (English))
- OJ-367 Randomized Comparison of Aggressive Versus Less Aggressive Rotational Atherectomy Followed by Coronary Stenting for Severe Calcified Lesions(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 10 (IHD) : OJ44)(Oral Presentation (Japane
- OJ-366 Effect of Preintervention Remodeling Type on Subsequent Coronary Artery Behavior after Directional Atherectomy(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 10 (IHD) : OJ44)(Oral Presentation (Japanese))
- OE-352 Long-Term Follow-Up after Percutaneous Coronary Intervention of a Chronic Total Occlusion in Native Coronary Arteries(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 13 (IHD) : OE44)(Oral Presentation (English))
- Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy : Initial and Follow-up Results in the First 27 Patients
- A Novel Drug Coating Stent Releasing Cilostazol for Inhibition of Neointimal Proliferation : Results of a Porcine Model of Coronary Restenosis
- Acute Result of a New Directional Coronary Atherectomy Catheter Compared with Standard Device : Intravascular Ultrasound Findings
- Clinical Efficacy of Percutaneous Intervention for Chronic Total Occlusion of Native Coronary Arteries with Saphenous Vein Graft Failure
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- The One Year Result of Parallel Wire Technique under Going Percutaneous Coronary Intervention of Chronic Total Occlusions
- Acute and Follow-Up Outcomes of Percutaneous Transluminal Septal Myocardial Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy
- Influence of Midventricular Obstruction on the Acute Results of Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy
- Beyond Five-Year Follow-Up after Stand-Alone Directional Coronary Atherectomy
- Late Regression of Target Lesions after Stand-Alone Directional Coronary Atherectomy
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Role of Chlamydia pneumoniae-infected macrophages in atherosclerosis developments of the carotid artery
- Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
- Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin's disease associated with Epstein-Barr virus
- Spontaneous closure of an unroofed coronary sinus
- Clonality analysis of granulocytes and T lymphocytes in healthy females by the PCR-based HUMARA method
- In Vitro Effects of Recombinant Human IL-11 on Human Malignant Lymphoma Cells
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Herb Water-extracts Markedly Suppress the Mutagenicity of Trp-P-2(Food & Nutrition)
- A Case of Arrhythmogenic Right Ventricular Dysplasia With Left and Right Ventricular Hypofunction in an Elderly Subject : Long-Term Fellow-Up
- Percutaneous Left Ventricular Assist System Using a Modification of the Dennis Method: Initial Clinical Evaluation and Results
- Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
- Expression of DMY and DMTR1 in Various Tissues of the Medaka (Oryzias latipes)(Reproductive Biology)
- Molecular evaluation of bone marrow involvement in peripheral T-cell lymphoma with a PCR-mediated RNase protection assay
- Role of Plaque Proliferation in Late Lumen Loss After Directional Coronary Atherectomy
- Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low-grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Ultrasonic Wave Amplification in Gaseous Plasmas
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Malignant Lymphoma and Tumor Suppressor Genes
- IgD monoclonal gammopathy of undetermined significance
- -547- AUGMENTED CONTRACTION FOLLOWING BLOCKED ATRIAL PREMATURE BEAT : COMPARISON WITH POSTEXTRASYSTOLIC POTENTIATION
- Percutaneous Transluminal Coronary Angioplasty for Multiple Lesions in a Coronary Artery-Report of Two Cases : REPORT OF A SATELITE SYMPOSIUM OF THE JAPANESE CIRCULATION SOCIETY ON THE INITIAL JAPANESE EXPERIENCE OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGI
- RISK FACTOR OF LEFT MAIN CORONARY ARTERY DISEASE : Ischemic Heart Disease (VI) : FREE COMMUNICATIONS (VI) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY : INDICATION ON THE BASIS OF DIAMETER OF CORONARY STENOSIS, AND EARLY AND LATE RESULTS : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Ischemic Heart Disease (II)
- REGIONAL MYOCARDIAL BLOOD FLOW IN THE REGION OF THE LEFT CORONARY ARTERY IN ANGINA PECTORIS : Coronary Circulation : 46th Annual Scientific Meeting, Japanese Circulation Society
- EVALUATION OF MYOCARDIAL VIABILITY IN ASYNERGIC WALL USING POSTEXTRASYSTOLIC POTENTIATION AND NITROGLYCERIN : Ichemic Heart Disease (II) : 46th Annual Scientific Meeting, Japanese Circulation Society
- EARLY RESULTS OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY : Ichemic Heart Disease (I) : 46th Annual Scientific Meeting, Japanese Circulation Society
- RISK FACTORS IN ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY DISESE (CAD) : Ischemic Heart disease : Ist Auditorium : Proceedings of the 43rd Annual Meeting of the Japanese Circulation Society, Tokyo, 1979
- -73-ROLE OF THE CORONARY COLLATERAL CIRCULATION IN PRESERVING LEFT VENTRICULAR FUNCTION : Ischemic Heart Disease : PROCEEDINGS OF THE 42nd ANNUAL MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Platelet activating factor causes a rapid increase in activity of prior expressed tissue factor on monocyte surface membrane
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Coronary Artery Bypass Grafting for a Patient With Tangier Disease
- Aortic Valve Replacement for a Patient with Porcelain Aorta and Retrosternal Gastric Tube Reconstruction after Esophageal Resection
- Mechanism of lumen loss after coronary intervention assessed by intravascular ultrasound : comparison of optimal lesion debulking and debulk-stenting
- Three-dimensional intravasucular ultraound analysis of in-stent neointimal proliferation comparing stenting after directional coronary atherectomy with primary stenting
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- Acute and long-term follow-up results of non-surgical septal myocardial ablation for hypertrophic obstructive cardiomyopathy
- Does optimal lesion debulking need stenting? : one year follow-up results of a prospective randomized trial
- Initial experiences in new atherectomy device Flexi-cut : efficacy on calcified lesions
- Biclonal Extramedullary Plasmacytoma Arising in the Peritoneal Cavity : Report of a Case
- Transluminal Percutaneous Septal Myocardial Ablation in a Patient With Hypertrophic Obstructive Cardiomyopathy
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- In Vitro Effects of Recombinant Human IL-11 on Human Malignant Lymphoma Cells
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Multiple Immune Abnormalities in a Patient with Idiopathic CD4+ T-Lymphocytopenia